North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Crizotinib
found
7 matches
Open monograph to display formulary status
BNF Category
Crizotinib
Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update (Nov 2015): Crizotinib (Xalkori▼): risk of cardiac failure (08.01.05)
NICE TA1021: Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer (08.01.05)
NICE TA406: Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (08.01.05)
NICE TA422: Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (08.01.05)
NICE TA529: Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer (08.01.05)
NICE TA571: Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib (08.01.05)